Clinical Outcomes of Patients with EGFR T790M+NSCLC on Osimertinib

被引：0

作者：

Tan, W. L. ^{[1
]}

Hennedige, T. P. ^{[2
]}

Ng, Q. S. ^{[3
]}

Tan, S. H. ^{[4
]}

Tran, N. T. A. ^{[5
]}

Chua, B. J. G. ^{[6
]}

Toh, C. K. ^{[3
]}

Tan, E. H. ^{[3
]}

Tan, D. ^{[3
]}

Ang, M. ^{[3
]}

Kanesvaran, R. ^{[3
]}

Jain, A. ^{[3
]}

Lim, T. K. H. ^{[7
]}

Gogna, A. ^{[8
]}

Koh, M. ^{[9
]}

Yip, C. S. P. ^{[10
]}

Thng, C. H. ^{[2
]}

Chowbay, B. ^{[11
]}

Tan, M. H. ^{[3
]}

Lim, W. ^{[3
]}

机构：

[1] Natl Canc Ctr Singapore, Med Oncol, Singapore, Singapore

[2] Natl Canc Ctr Singapore, Oncol Imaging, Singapore, Singapore

[3] Natl Canc Ctr, Med Oncol, Singapore, Singapore

[4] Natl Canc Ctr Singapore, Clin Trial Off, Singapore, Singapore

[5] Moh Holdings, Diagnost Radiol, Singapore, Singapore

[6] Moh Holdings, Singapore, Singapore

[7] Singhealth, Anat Pathol, Singapore, Singapore

[8] Singhealth, Diagnost Radiol, Singapore, Singapore

[9] Singhealth, Pulmonol, Singapore, Singapore

[10] Natl Canc Ctr Singapore, Radiat Oncol, Singapore, Singapore

[11] Natl Canc Ctr Singapore, Med Sci & Clin Pharmacol, Singapore, Singapore

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期

关键词：

EGFR T790M; osimertinib; NSCLC;

D O I：

10.1016/j.jtho.2017.09.1458

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.01-017

引用

页码：S2206 / S2206

页数：1